Latest NewsAug 22, 2024HiFiBiO Therapeutics to Present Phase 1 Clinical Trial Data for Two Novel Immuno-Oncology Antibodies at the 2024 Annual Congress of the European Society for Medical OncologyAll Filter By: Year2024202320222021202020192018201720162015Mar 21, 2024HiFiBiO Therapeutics to Present at 2024 American Association for Cancer Research Annual MeetingNasdaq Live from MarketSite | Interview | Jan 7, 2024CEO Liang Schweizer Sits with Nasdaq to Share HiFiBiO Therapeutics’ Mission to Unlock the Curative Powers of the Immune SystemDec 11, 2023HiFiBiO Therapeutics Collaborates with Institut Gustave Roussy and France 2030 Initiative to Pioneer Personalized ImmunotherapiesNov 8, 2023HiFiBiO Therapeutics Drug Intelligence Science DIS® Platform Wins “AI Innovation of the Year” in 2023 BioTech Breakthrough AwardsOct 23, 2023Drug Intelligence Science (DIS®) – A Cutting-Edge Translational Platform Pioneered by HiFiBiO Therapeutics – Featured in Drug Discovery TodayOct 9, 2023HiFiBiO Therapeutics Receives Approval from Chinese NMPA for IND Application for HFB200301, an Innovative Anti-Tumor Monoclonal Antibody< 1 2 3 4 … 14 >
